Poxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy
LYON, France--(BUSINESS WIRE)-- Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for ...